A Phase 2 Randomized Double-Blind Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Ulcerative Colitis

Brief description of study

Bristol-Myers Squibb Company (the Sponsor) is running a clinical research study to see if an investigational drug, named BMS-986165, will help in the treatment of ulcerative colitis, and how safe it is to use in people. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA). Clinical research studies in humans are done to find better ways to treat diseases and medical conditions.


Clinical Study Identifier: s19-00651
ClinicalTrials.gov Identifier: NCT03934216
Principal Investigator: David P Hudesman.


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.